
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+4
Zymeworks is a global clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks mission is to make a meaningful difference in the lives of people impacted by difficult-to-treat cancers and other diseases. The Companys complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates. Zymeworks engineered and developed zanidatamab, a HER2-targeted bispecific antibody using the Companys proprietary AzymetricTM technology. Zymeworks has entered into separate agreements with BeiGene, Ltd. (BeiGene) and Jazz Pharmaceuticals Ireland Limited (Jazz), granting each exclusive rights to...
Antibody therapeutics,bispecific antibodies,effector function modulation,adc,breast cancer,gastric cancer,protein engineering,immune redirection,and biliary tract cancer
Zymeworks inc operates in the Biotechnology research industry.
Zymeworks inc's revenue is 11m - 100m
Zymeworks inc has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.